pantoprazole sodium NDC 70010-190

NDC codes

FDA NDC Directory

Product NDC (as listed)70010-190Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70010-0190Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70010-190-09	70010019009	90 TABLET, DELAYED RELEASE in 1 BOTTLE (70010-190-09)Marketed from Apr 12, 2024
70010-190-10	70010019010	1000 TABLET, DELAYED RELEASE in 1 BOTTLE (70010-190-10)Marketed from Apr 12, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): pantoprazole sodium
Generic name (nonproprietary): pantoprazole sodium
Active ingredients: Pantoprazole sodium — 20 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Granules Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217282
Marketing start: Apr 12, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Proton Pump Inhibitors (Mechanism)
Identifiers: Product ID 70010-190_4ec4732c-38ba-bcc3-e063-6294a90a823cSPL ID 4ec4732c-38ba-bcc3-e063-6294a90a823cSPL set ID 8f2fb647-15bc-41cb-84a4-02e956e614fcRxCUI 251872, 314200UNII 6871619Q5XUPC 0370010190092, 0370010191099
Pharmacologic class: Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470010019009 followed by a unit qualifier and the quantity

Package 70010-0190-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 6, 2026.

Indications (excerpt from the label)

Pantoprazole sodium delayed-release tablets are indicated for: Pantoprazole sodium is a proton pump inhibitor (PPI) indicated for the following: Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) ( 1.1 ) Maintenance of Healing of Erosive Esophagitis ( 1.2 ) Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome ( 1.3 ) 1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD) Pantoprazole sodium is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis (E…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217282

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217282
Product	Strength	Form · route	Labeler	Product NDC
pantoprazole sodium	Pantoprazole sodium 40 mg/1	Tablet, Delayed releaseOral	Granules Pharmaceuticals Inc.	70010-191